Decentralized clinical trials platform Medable now valued at $2.1B

Healthcare

Medable recently raised $304 million, its fourth funding round in the past two years. The company’s software can be used to virtually consent patients into clinical trials and run telehealth visits as part of a trial. 

Leave a Reply